Lidocaine Hydrochloride And Epinephrine Injection, Solution
Product Images NDC 0404-9891

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Epinephrine (NDC 0404-9891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Formula2.jpg (Formula2)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This is a table that provides concentrations of Lidocaine HCI and Epinephrine in milligrams per milliliter (mg/ml) for different percentages ranging from 0.5% to 2%. The table also shows the ratios for Epinephrine concentration beyond percentage, ranging from 1:100,000 to 1:200,000. These concentrations can be used for medical purposes, such as anesthesia or medical procedures, but the specific purpose is not available in this text.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
This text describes the recommended products for epidural anesthesia with Lidocaine Hydrochloride and Epinephrine Injection, USP by Hospira. The available products include 1% with epinephrine 1:200,000 in 30 mL single-dose vials, 1.5% with epinephrine 1:200,000 in 0 mL single-dose vials, and 2% with epinephrine 1:200,000 in 0 mL single-dose vials. The text also mentions a 1.5% solution with epinephrine 1:200,000 in mL single-dose ampuls.*
FDA Label Image

Image3.jpg (Image3)

FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
This is a table displaying recommended dosages for Lidocaine Hydrochloride Injection, USP (without Epinephrine) for various medical procedures, including infiltration, peripheral nerve blocks, sympathetic nerve blocks, central neural blocks, analgesia, and anesthesia. The table provides values for procedure concentration, volume, and total dose in milligrams.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This is a description of a medication called Lidocaine HCL 1% and Epinephrine 1:100,000 Injection, USP. It is a multiple-dose vial used for infiltration and nerve block. It cannot be used for epidural or caudal use. It should not be autoclaved, and its use is prohibited if the injection is pinkish, darker than slightly yellow, or contains a precipitate. The medication should be stored at a controlled temperature of 68°F to 77°F and kept out of children's reach. The manufacturer is not mentioned in the text. Lot number and expiry date are also provided.*
FDA Label Image

Label2.jpg (Label2)

FDA Label Image

Label3.jpg (Label3)

Label3.jpg (Label3)
This is a description of a medication called Lidocaine HCL 1% and Epinephrine 1:100,000 that is an injection in multi-dose vial presentation. It is used for infiltration and nerve block but not for epidural or caudal use. It should not be autoclaved and retained in the bag until contents are used. It is sterile, non-pyrogenic and should not be used if the injection solution is pinkish or darker than slightly yellow or if it contains precipitate. The medication should be stored out of children's reach at a controlled temperature between 68F to 77F. The manufacturer of this product is Hospira. The product should only be used with prescription and additional information is available in the manufacturer's insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.